New mesothelioma treatment study looks at miR-31 | mesothelioma .
Rosetta Genomics, Ltd as well as the NYU Langone Health examination Center recently published a joint study called the %26ldquo;Pro-tumorigenic.
Blog Content
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment